{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-003057","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.196902+00:00","generated_at":"2026-06-06T21:21:18.742922+00:00","sec_items":["2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"AgeX draws $500K under existing secured note with Juvenescence, due Feb 14, 2024","bullets":["$500,000 drawn on Jan 16, 2024 from Amended & Restated Secured Convertible Note with Juvenescence Ltd.","Repayment date set for February 14, 2024 (approximately one month).","Full terms of Secured Note previously disclosed in Nov 14, 2023 10-Q filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-003057","json":"https://secwatch.observer/filing/0001493152-24-003057.json","markdown":"https://secwatch.observer/filing/0001493152-24-003057.md","text":"https://secwatch.observer/filing/0001493152-24-003057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224003057/0001493152-24-003057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224003057/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:21:18.742922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b5d90439a7bd3b07538e63c44565a6bff86d9a0e","claim":"Serina Therapeutics, Inc. incurred convertible notes of $500,000 with Juvenescence Limited maturing February 14, 2024.","evidence_excerpt":"On January 16, 2024, AgeX drew $500,000 of its credit available under the Amended and Restated Secured Convertible Promissory Note, as amended, (“Secured Note”) with Juvenescence Limited (“Juvenescence”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224003057/0001493152-24-003057-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$500,000"},{"label":"Counterparty","value":"Juvenescence Limited"},{"label":"Maturity","value":"February 14, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}